IUB® PRIMA®
Endometriosis, uterine fibroids, hormonal disorders
Pre‑clinicalActive
Key Facts
Indication
Endometriosis, uterine fibroids, hormonal disorders
Phase
Pre‑clinical
Status
Active
Company
About OCON Therapeutics
Innovative Nitinol‑based intrauterine platform delivering hormone‑free contraception and targeted therapies for women’s health.
View full company profile